5G / 6G Policy & Regulation

RF Safe argues that Media Bias/Fact Check (MBFC) downgraded RF Safe partly by citing an FDA webpage stating typical RF exposure is not supported by current evidence as a health risk, but that the cited FDA page now redirects to a general “Cell Phones” landing page. The post claims other historically cited FDA consumer pages also redirect and that the strongest reassurance language is now mainly accessible via archives. It further cites Reuters reporting that FDA removed outdated webpages about cellphone safety alongside HHS launching a new study, and contends MBFC should update its rationale and links.

RF Safe criticizes Media Bias/Fact Check (MBFC) for rating it “medium credibility,” arguing MBFC relied on an FDA webpage that was later changed/redirected and on a Harvard T.H. Chan School commentary. The post claims the FDA removed categorical reassurance language about cell phone safety and frames this as undermining MBFC’s critique. It also asserts that non-thermal mechanisms and animal findings support RF Safe’s precautionary stance, while characterizing MBFC’s sources as “opinion” rather than data.

This RF Safe commentary argues that HHS, under Secretary Robert F. Kennedy Jr., was correct to remove FDA webpages that gave broad assurances that cell phone radiation is “not dangerous.” It claims blanket safety messaging is scientifically indefensible given animal toxicology findings (notably the U.S. National Toxicology Program studies), a WHO-commissioned systematic review of animal cancer studies (Mevissen et al., 2025), and references to federal court findings. The piece frames the change as a precautionary, science-based correction rather than an anti-science move.

This RF Safe commentary argues that Reuters-reported actions by HHS and FDA—launching an HHS study and removing older FDA webpages stating cellphones are “not dangerous”—should be understood as a risk-communication/scientific-integrity adjustment rather than a declaration of confirmed harm. It contends that categorical safety messaging is not justified given mixed evidence, citing the D.C. Circuit’s 2021 decision criticizing FCC reliance on conclusory FDA statements, along with selected human, animal, and mechanistic literature. The post calls for more uncertainty-aware, evidence-graded public messaging about RF exposure from phones.

This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review (Mevissen et al., 2025) as motivation, emphasizing reported tissue-selective findings and non-monotonic dose patterns. The post proposes a mechanistic framework (“S4–Mito–Spin”) and calls for research to map boundary conditions across tissues and exposure parameters to inform standards beyond SAR/thermal assumptions.

This RF Safe article reports that in mid-January 2026 HHS, led by Secretary Robert F. Kennedy Jr., removed or redirected certain FDA webpages that previously conveyed strong “no-risk” conclusions about cellphone radiation. It argues the updated FDA framing emphasizes statutory duties (monitoring, testing, hazard control) and signals a shift from definitive safety messaging toward renewed inquiry, while noting that details of any planned research have not been publicly disclosed. The piece also highlights Kennedy’s past public statements alleging harms from Wi‑Fi/5G and links the policy context to the 2021 D.C. Circuit remand of FCC RF policy.

RF Safe reports that HHS confirmed plans to launch a new study on cellphone radiation and that an HHS spokesperson said the FDA removed webpages with “old conclusions” while new research is undertaken to identify knowledge gaps, including for emerging technologies. The article frames the FDA webpage changes as a meaningful shift away from categorical reassurance, while noting Reuters’ reporting that some FDA and CDC pages still state there is no credible evidence of health problems from cellphone radiation. It also links the development to the 2021 D.C. Circuit decision in Environmental Health Trust v. FCC, arguing the ruling exposed weaknesses in the FCC’s reliance on other agencies’ statements.

RF Safe reports that the U.S. FDA substantially revised its cellphone radiation webpages around January 15, 2026, removing or reducing prior language that broadly reassured the public about safety. The article argues the new framing more closely reflects the FDA’s statutory responsibilities under the Radiation Control for Health and Safety Act of 1968 (Public Law 90-602), emphasizing research, monitoring, and public information rather than definitive safety conclusions. It also links the change to a reported HHS announcement of a new study and portrays the update as a shift toward greater transparency, while noting some safety language may remain on the page.

RF Safe promotes its QuantaCase (also called TruthCase) as a leading “anti-radiation” phone case for 2026, emphasizing a directional shielding design intended to deflect RF energy away from the body. The article argues the product aligns with consumer-safety guidance such as keeping phones away from the body and using hands-free modes, and it claims RF Safe’s earlier advocacy influenced FTC/FCC warnings about ineffective or counterproductive shielding products. It cites comparisons, user reviews, and an “independent” 2017 TV review as support, but presents limited verifiable technical detail in the excerpt.

RF Safe critiques the anti-radiation phone case market for relying on headline percentage-blocking claims that may reflect tests of shielding material rather than real-world phone behavior in a case on a live network. The article argues that poorly designed or misused shielding cases can interfere with a phone’s signal and prompt higher transmit power, potentially increasing exposure in some scenarios. It positions RF Safe’s QuantaCase/TruthCase as avoiding percentage marketing claims and emphasizes a systems-engineering approach to testing and use, while noting that health causation from typical consumer RF exposure remains debated by authorities.

RF Safe argues that “anti-radiation” phone case marketing based on universal “99% blocking” claims is misleading because real-world phone emissions vary with signal conditions, orientation, and how a case affects the antenna. The post positions RF Safe’s TruthCase/QuantaCase as more credible specifically because it refuses to advertise a single percentage reduction and instead emphasizes design constraints intended to avoid prompting a phone to increase transmit power. It cites a KPIX 5 (CBS San Francisco) test as an example of how flip cases can reduce exposure in some configurations but potentially increase it in others when used differently than intended.

RF Safe argues that many “anti-radiation” phone cases market misleading “% blocked” claims based on lab material tests rather than whole-device, real-world performance. The article promotes RF Safe’s TruthCase/QuantaCase as a “physics-first” design that avoids advertising a single blocking percentage and emphasizes directional shielding and user education. It cites a 2017 CBS San Francisco/KPIX test as an example of how some flip-style shielding cases can reduce measured RF in certain orientations but may increase readings in other common-use configurations.

RF Safe argues that “no effect” findings in some RF exposure studies should be interpreted as meaningful negative controls rather than as evidence that RF has no biological effects. The post presents RF Safe’s “S4–Mito–Spin” framework, claiming certain skin cell types (fibroblasts and keratinocytes) are predicted to be relatively resistant to non-thermal RF effects, so null results in these cells can be consistent with the model. It cites in-vitro studies at 3.5 GHz (5G-modulated) reporting no changes in ROS measures, stress responses, or UV-B DNA repair kinetics under specified SAR conditions, and frames these nulls as boundary conditions rather than a general safety conclusion.

This RF Safe commentary frames readers as part of a “resistance” movement seeking changes to U.S. wireless policy and RF exposure governance. It argues that current FCC RF exposure rules and related laws constrain local decision-making and rely on a “thermal-only” safety framework that the author says is outdated. The post cites a WHO-commissioned 2025 systematic review on RF-EMF and cancer in experimental animals as part of a broader WHO review effort, and advocates shifting indoor connectivity toward light-based technologies.

RF Safe argues that its “S4-Mito-Spin” framework should avoid debates about whether cell phones cause human disease and instead focus on mechanistic and animal evidence for non-thermal RF/EMF biological effects. The post claims the framework synthesizes established concepts (ion-channel interactions, mitochondrial/NOX-driven ROS, and radical-pair/quantum spin effects) to explain why some lab studies find effects and others do not. It also cites a WHO-commissioned systematic review and a U.S. court ruling to support calls for updating RF exposure guidelines beyond thermal-only assumptions.

RF Safe argues that its “S4-Mito-Spin” framework should avoid human disease causation debates and instead focus on interpreting non-thermal RF/EMF findings from cellular and animal studies. The article claims the framework synthesizes mechanisms involving voltage-gated ion channels, mitochondrial/oxidative stress pathways, and radical-pair (spin) effects to explain why some experiments show effects and others do not. It further contends that rodent evidence and a cited WHO-commissioned review support updating RF exposure guidelines beyond thermal-only assumptions, and references a U.S. court decision criticizing the FCC’s rationale for maintaining existing limits.

RF Safe publishes a rebuttal to Media Bias Fact Check’s (MBFC) decision to rate the site “Medium Credibility,” addressing MBFC’s concerns about selective citation, one-sided interpretation, alarmist framing, and potential conflicts of interest tied to selling RF-safety products. The post argues RF Safe includes null/negative findings, avoids claiming RF “causes” specific diseases, and maintains editorial/transparency policies meant to separate evidence types and disclose commercial relationships. It also contends MBFC’s critique is partly a dispute over tone and wording (e.g., “primarily” funded by product sales) rather than demonstrated sourcing errors.

RF Safe publishes a rebuttal to Media Bias Fact Check’s (MBFC) January 8, 2026 credibility assessment, arguing MBFC’s “Medium Credibility” rating is unjustified despite MBFC upgrades to “Least Biased” and “Mostly Factual.” The post disputes MBFC’s criticisms (selective citation, alarmist framing, and potential conflict of interest from product sales) and claims RF Safe’s coverage aligns with WHO-commissioned reviews and legal/regulatory developments. RF Safe reiterates its view that thermal-only RF exposure guidelines are inadequate and calls for policy reform while stating it does not claim definitive human causation.

RF Safe publishes a commentary disputing Media Bias Fact Check’s (MBFC) labeling of RF Safe as “pseudoscience” with “mixed factual reporting” and “low credibility.” The post argues MBFC mischaracterized RF Safe’s content as overstating evidence about cell phones and health, claiming RF Safe generally uses cautious, study-referencing language (e.g., “associations,” “potential risks”) and avoids asserting direct human causation. It also points to RF Safe disclaimers that the site is educational and not medical advice, and highlights its research library linking to primary studies such as NTP and Ramazzini animal findings.

This PubMed-listed paper argues that the U.S. regulatory framework for radiofrequency radiation (RFR) from wireless technologies is outdated, lacks adequate oversight and enforcement, and has not been meaningfully updated since 1996. It contends that FCC exposure limits focus on short-term, high-intensity effects and do not address long-term, low-intensity exposures, with insufficient safeguards for children, pregnancy, and other vulnerable groups. The authors also discuss alleged regulatory capture, gaps in monitoring and compliance, and propose reforms including independent research, updated safety limits, and stronger pre- and post-market surveillance.

RF Safe argues that celebrity-branded mobile services (citing reported plans for “Beast Mobile” and the announced “Trump Mobile”) could normalize near-body, all-day phone use—especially among children—and therefore carry ethical responsibility for scaled RF exposure. The piece cites legal and scientific developments (including the 2021 Environmental Health Trust v. FCC decision, the U.S. NTP animal studies, and a WHO-commissioned systematic review) to claim the evidence base has “moved decisively” toward concern about long-term RF-EMF effects. It also promotes a proposed mechanistic framework ("S4–Mito–Spin") and suggests shifting indoor connectivity toward Li‑Fi (IEEE 802.11bb) as a harm-reduction approach.

This RF Safe commentary argues that U.S. RF exposure protections remain anchored to “thermal-only” assumptions from the 1990s despite what it describes as newer WHO-commissioned systematic reviews elevating certain animal cancer endpoints and a male fertility endpoint to “high certainty.” It contrasts these claims with a WHO-commissioned review of human observational studies that reportedly found mobile-phone RF exposure is likely not associated with increased risk of several head/brain tumors, arguing that this is often overgeneralized in public messaging. The piece calls for “prudent avoidance,” updates to FCC rules, and highlights legal and policy constraints such as federal preemption under the Telecommunications Act and a 2021 D.C. Circuit decision criticizing the FCC’s rationale for retaining its RF limits without adequate explanation.

RF Safe argues that recent WHO-linked evidence reviews have moved beyond a “thermal-only” safety narrative and that policy should respond with stronger protections. The post cites a 2025 WHO-commissioned systematic review in Environment International as concluding with “high certainty” that RF-EMF increases malignant heart schwannomas and brain gliomas in male rats, and references a 2025 corrigendum upgrading certainty for reduced pregnancy rates after male RF exposure in animal experiments. It also points to U.S. FCC rules being rooted in 1996-era assumptions and references a U.S. appellate court remand requiring the FCC to better address non-cancer harms and impacts on children and long-term exposure. The article advocates for the “Clean Ether Act” and promotes RF Safe’s proposed “S4–Mito–Spin” mechanism framework as a non-thermal explanatory model.

RF Safe argues that children’s everyday wireless exposure is primarily shaped by policy choices (laws, agency guidance, research mandates, and procurement practices) rather than by technology alone. The post promotes an “Act Now” hub that offers coordinated advocacy actions aimed at changing federal and local rules, increasing research and oversight, and shifting indoor connectivity toward alternatives such as Li‑Fi. It frames current governance as outdated and restrictive, particularly around local authority and federal agency accountability.

RF Safe promotes an “Act Now” hub intended to convert EMF safety concerns into policy and regulatory actions, emphasizing accountability and exposure reduction, especially for children. The page outlines five advocacy “levers,” including changing Section 704 of the Telecommunications Act, pressing the FCC to complete actions following a court remand, and restarting a federal electronic-product radiation program. It frames current RF oversight as outdated and insufficient for modern exposure patterns, and provides scripts to help supporters submit comments and demands into official records.

This animal study tested whether short-term 28 GHz (5G-band) millimeter-wave exposure modifies doxorubicin-induced cardiotoxicity in male rats and whether vitamin C mitigates effects. Co-exposure to 28 GHz EMR was reported to worsen several indices of DOX-related cardiac injury (including CAT reduction, increased BAX expression, and QT prolongation), while vitamin C provided partial attenuation. The authors emphasize that results are limited to a short-duration preclinical model and that human relevance remains preliminary.